Cargando…
基于代谢组学的多西他赛调控肺癌细胞代谢重编程研究
BACKGROUND AND OBJECTIVE: Docetaxel is a commonly used anti-tumor drug in clinic, especially as the first-line drug for advanced non-small cell lung cancer (NSCLC). However, the molecular mechanism of docetaxel against NSCLC is still unclear. Increasing studies have shown that metabolic reprogrammin...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500501/ https://www.ncbi.nlm.nih.gov/pubmed/31014438 http://dx.doi.org/10.3779/j.issn.1009-3419.2019.04.02 |